Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
23.01. | RANGE IMPACT, INC. - 8-K, Current Report | - | SEC Filings | ||
23.01. | Joseph LoConti von Range Impact erwirbt Stammaktien im Wert von 499.999 US-Dollar | 1 | Investing.com Deutsch | ||
19.12.24 | RANGE IMPACT, INC. - S-1/A, General form for registration of securities | - | SEC Filings | ||
RANGE IMPACT Aktie jetzt für 0€ handeln | |||||
04.12.24 | RANGE IMPACT, INC. - S-1/A, General form for registration of securities | - | SEC Filings | ||
14.11.24 | RANGE IMPACT, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
13.11.24 | RANGE IMPACT, INC. - 8-K, Current Report | - | SEC Filings | ||
15.10.24 | Range Impact revises Q1 financials due to accounting error | 1 | Investing.com | ||
15.10.24 | RANGE IMPACT, INC. - 8-K, Current Report | - | SEC Filings | ||
15.10.24 | RANGE IMPACT, INC. - 10-Q/A, Quarterly Report | 1 | SEC Filings | ||
07.10.24 | Range Impact, Inc.: Range Impact Announces Uplisting to the OTCQB Venture Market | 127 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public company dedicated to improving the health and wellness of people and... ► Artikel lesen | |
02.10.24 | Range Impact announces sale of cannabinoid drug development business | 1 | Seeking Alpha | ||
02.10.24 | Range Impact, Inc.: Range Impact Announces Sale of Cannabinoid Drug Development Business | 119 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact" or the "Company"), a public company dedicated to improving the health and wellness of people and the... ► Artikel lesen | |
02.10.24 | RANGE IMPACT, INC. - 8-K, Current Report | 1 | SEC Filings | ||
20.09.24 | Range Impact, Inc.: Range Impact Announces Application to Uplist to the OTCQB Venture Market | 1 | GlobeNewswire (USA) | ||
29.08.24 | Range Impact sells non-core assets | 1 | Seeking Alpha | ||
29.08.24 | Range Impact, Inc.: Range Impact Announces Sale of Non-Core Assets as Part of Strategic Plan | 241 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact" or the "Company"), a public company dedicated to improving the health and wellness of people and the... ► Artikel lesen | |
29.08.24 | RANGE IMPACT, INC. - 8-K, Current Report | - | SEC Filings | ||
14.08.24 | Range Impact, Inc.: Range Impact Reports 2Q 2024 Financial Results | 341 | GlobeNewswire (Europe) | CLEVELAND, OHIO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact"), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites... ► Artikel lesen | |
15.05.24 | Range Impact, Inc.: Range Impact Reports 1Q 2024 Financial Results | 139 | GlobeNewswire (Europe) | CLEVELAND, OHIO, May 15, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact"), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites in... ► Artikel lesen | |
29.03.24 | Range Impact, Inc.: Range Impact Reports 4Q 2023 and Full Year 2023 Financial Results | 193 | GlobeNewswire (Europe) | CLEVELAND, OHIO, March 29, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) ("Range Impact"), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
NOVO NORDISK | 83,93 | -0,21 % | DEUTSCHE BANK RESEARCH stuft NOVO NORDISK auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Novo Nordisk mit einem Kursziel von 900 dänischen Kronen auf "Buy" belassen. Obwohl die Zulassung des Diabetes- und Schlankheitsmittels... ► Artikel lesen | |
AURORA CANNABIS | 5,635 | +0,36 % | Aurora Cannabis Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
CANOPY GROWTH | 1,566 | +0,77 % | Canopy Growth: Buffett steigt (indirekt) ein | Aus den jüngsten 13F-Berichten geht hervor, dass Warren Buffett beim größten Wein-Produzenten der Welt, Constellation Brands, eingestiegen ist. Damit geht Buffett auch ein - höchstwahrscheinlich ungewolltes... ► Artikel lesen | |
TILRAY BRANDS | 0,900 | +2,65 % | Tilray Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
VERTEX PHARMACEUTICALS | 465,50 | +0,52 % | Vertex Pharmaceuticals Incorporated (VRTX): Among Renaissance Technologies Portfolio's Top Stock Picks | ||
TAAT GLOBAL ALTERNATIVES | 0,157 | 0,00 % | TAAT Global Alternatives Inc (2): TAAT Global closes acquisition of Premium Products | ||
CRONOS GROUP | 1,836 | -2,29 % | Cronos-Aktie: Lohnt sich hier ein Kauf? | Die Aktie von Cronos ist wie die meisten Cannabiswerte in den vergangenen Monaten unter Druck geraten. Doch ist der kanadische Titel jetzt einen Blick für Anleger wert? Immerhin winken hier vergleichsweise... ► Artikel lesen | |
DIGICANN VENTURES | 0,004 | 0,00 % | CSE Bulletin: Halted for Fundamental Change - Digicann Ventures Inc. (DCNN) | le 30 septembre/September 2024
Trading in the shares of Digicann Ventures Inc. will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Change pursuant... ► Artikel lesen | |
EYEPOINT PHARMACEUTICALS | 6,168 | +4,83 % | EyePoint Pharmaceuticals, Inc.: EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | WATERTOWN, Mass., Feb. 17, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients... ► Artikel lesen | |
ORGANIGRAM | 1,168 | -6,41 % | Organigram Reports First Quarter Fiscal 2025 Results | TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced its results for the first quarter... ► Artikel lesen | |
GREEN THUMB INDUSTRIES | 6,725 | -1,61 % | Multi-Bagger entdeckt!: Der europäische Cannabissektor wird in den nächsten Jahren auf 24 Mrd. $ explodieren - diese Aktie profitiert! | ||
MYDECINE INNOVATIONS GROUP | 0,004 | -12,50 % | Mydecine Innovations Group Inc - Mydecine Announces Filing of Q3 Financial Statements | Mydecine Innovations Group Inc - Mydecine Announces Filing of Q3 Financial Statements
PR Newswire
LONDON, United Kingdom, November 21
MYDECINE ANNOUNCES FILING OF Q3 FINANCIAL... ► Artikel lesen | |
ASTRIA THERAPEUTICS | 6,350 | -3,05 % | JMP SECURITIES REITERATES ASTRIA THERAPEUTICS OUTPERFORM RATING | ||
SANTHERA PHARMACEUTICALS | 17,123 | +0,60 % | Santhera Pharmaceuticals Holding AG: Santhera Announces Agreement with German GKV-SV on Reimbursement Amount for AGAMREE (vamorolone) for the Treatment of Duchenne Muscular Dystrophy in Germany | Ad hoc announcement pursuant to Art. 53 LR
AGAMREE® is the first product to receive an agreed federal price in Germany for the treatment of all DMD patients 4 years and older, and independent of... ► Artikel lesen | |
TONIX PHARMACEUTICALS | 9,135 | -5,53 % | Tonix Pharmaceuticals Holding Corp. - 8-K, Current Report |